How do I lower my risk of depression?

Our read is that consistent daily morning light exposure and endurance exercise are crucial for regulating the circadian system and beneficially altering kynurenine metabolism, respectively, both of which can positively affect depression.

Additionally, an ancestral lifestyle, including nose-to-tail eating and avoiding processed foods, may address depression, while certain pharmaceutical interventions like SSRIs and ketamine offer relief for many, though their efficacy and side effects warrant careful consideration.

Conversely, cannabis use between ages 16-24 and seed oils in foods are noted as increasing the likelihood of depression, and traditional Western medical models may be lacking if they do not address neuroinflammation.

Consistent daily morning light exposure involves ensuring light exposure each morning. Endurance exercise beneficially alters kynurenine metabolism by increasing muscle tissue activity of kynurenine amino transferase. An ancestral lifestyle includes nose-to-tail eating and avoiding processed foods. Red light therapy can be applied to the forehead.

• 01Andrew Huberman states that consistent daily morning light exposure is crucial for regulating the circadian system and can have positive effects on depression.
• 02Andrew Huberman and Rhonda Patrick emphasize that endurance exercise can beneficially alter kynurenine metabolism by increasing muscle tissue activity of kynurenine amino transferase.
• 03Paul Saladino suggests that an animal-based diet focused on meat and organs with limited carbohydrates from fruit and honey may improve depression, and an ancestral lifestyle, including nose-to-tail eating and avoiding processed foods, can address depression.
• 04Andrew Huberman notes that SSRIs provide relief for symptoms in two-thirds of individuals with depression and prevent serotonin reuptake from the synapse, increasing its availability between neurons.
• 05Andrew Huberman also indicates that ketamine-induced bursting patterns of electrical activity in excitatory neurons can induce long-term changes in neural circuits associated with reward, dopamine release, and mood, relieving major depression.
• 06Bryan Johnson suggests that red light therapy applied to the forehead can be useful for depression.
• 07David Sinclair points out that chronic cortisol, interferon-alpha, and loss of SIRT1 cause dendritic atrophy, synapse loss, reduced glutamate signaling, and neuronal hypoactivity in prefrontal cortex neurons.
• 08Rhonda Patrick states that colonic inflammation from gut endotoxin can cause chronic reactive oxygen species that damage cells and affect brain function, leading to depression.
• 09Andrew Huberman warns that cannabis use between ages 16-24 increases the likelihood of developing major depression, severe anxiety, or psychosis later in life.
• 10Peter Attia notes that Jeepperone (Exua) shows no greater probability than placebo to reduce sex drive or alter food consumption patterns.

Our read is that traditional psychiatric medications for depression can cause significant weight gain and may not effectively resolve underlying disability, as Paul Saladino points out. Paul Saladino also argues that Western medical treatment models for depression may be lacking because they do not address neuroinflammation, and that treating psychiatric conditions solely by increasing neurotransmitters may be ineffective if underlying brain inflammation is not addressed. He further states that seed oils in foods contribute to adults becoming anxious and depressed. Andrew Huberman notes that current vagus nerve stimulation methods are dose-limited due to stimulating nearby cells, causing side effects like hoarseness, swallowing difficulties, and breathing trouble. David Sinclair suggests that a subset of individuals may be vulnerable to cholesterol-lowering drugs if their brain cholesterol or SIRT1/NAD+ levels are compromised. Andrew Huberman advises that individuals should not avoid taking prescribed antidepressant medications if their clinician deems it important for their survival.

Our read is that the verdict would change with new evidence on the long-term efficacy and safety of current treatments, or if more precise methods for targeting neural pathways, such as optogenetics, become widely available and proven effective for depression without significant side effects. Additionally, further research into the role of diet and inflammation in depression, particularly regarding specific dietary components and their mechanisms, could alter our understanding and recommendations.